HIV Post-Exposure Prophylaxis (PEP)–Effect on Management of Bloodborne Pathogen Exposures in the Health Care Environment

Aegis. (2001). Timeline: A brief history of AIDS/HIV. In The HIV daily briefing. Retrieved July 12, 2003, from http://www.aegis.com/topics/timeline/default.asp

Avert. (2003, February 12). What is HIV antiretroviral treatment? In Averting HIV & AIDS. Retrieved July 14, 2003, from http://www.avert.org/introtrt.htm

Centers for Disease Control and Prevention. (2001a). Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report, 50(RR-11), 1–32.

Centers for Disease Control and Prevention. (2001b). Appendix C: Basic and expanded HIV postexposure prophylaxis regimens. Morbidity and Mortality Weekly Report, 50(RR-11), 47–52.

Centers for Disease Control and Prevention. (2001c, June 26). Mortality declines for several leading causes of death in 1999. In CDC media relations. Retrieved July 14, 2003, from http://www.cdc.gov/od/oc/media/pressrel/r010626.htm

Garcia de Olalla P. , Knobel H. , Carmona A. , Guelar A. , Lopez-Colomes J.L. , & Cayla J.A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients [Electronic version]. Journal of Acquired Immune Deficiency Syndromes, 30(1), 105–110.

Healthcommunities. (2003, July 12). HIV and AIDS. In LGBT health channel: Your WET health community. Retrieved July 12, 2003, from http://www.lgbthealthchannel.com/hivaids/history.shtml

Ippolito, G., Puro, V., De Carli, G., Italian Study Group on Occupational Risk of HIV Infection. (1993). The risk of occupational human immunodeficiency virus in health care workers. Archives of Internal Medicine, 153, 1451–1458.

Katz M.H. , & Hollander H. (2000). HIV infection. In, Tierney L.M. , McPhee S.J. , & Papadakis M.A. (Eds.), Current medical diagnosis & treatment: 2000 (39th ed., pp. 1266–1294). Columbus, OH: Lange Medical Books/McGraw-Hill.

University of California, Los Angeles (UCLA). (1998, November 10). VCLA study shows illness and death have dropped sharply since introduction of antiretroviral treatment for HIV. Retrieved July 14, 2003, from http://www.ph.ucla.edu/sph/pr/wr516.html

University of California, San Francisco (UCSF). (2003, April). Antiretroviral drugs: Adverse reactions, and interaction potential. In National HIV/AIDS clinicians’ consultation center. Retrieved June 2, 2003, from http://www.ucsf.edu/hivcntr/Clinical_Resources/Pharmacy/ARVtable.htm